Lefaucheur C, Nochy D, Amrein C, Chevalier P, Guillemain R, Cherif M, Jacquot C, Glotz D, Hill G S
Department of Nephrology and Kidney Transplantation, Saint-Louis Hospital Paris, France.
Am J Transplant. 2008 Sep;8(9):1901-10. doi: 10.1111/j.1600-6143.2008.02342.x. Epub 2008 Jul 28.
We have analyzed the evolution of renal status beyond the perioperative period in patients with cystic fibrosis (CF) undergoing lung transplantation and presented histological analysis of 15 patients biopsied for an episode of accelerated renal function loss (RFL). Episodes of accelerated RFL after the perioperative period occurred in 32.5% of patients and significantly raised the risk of end-stage renal disease (ESRD) (p < 0.001). The histologic lesions associated with these episodes differed according to the time of onset. Early onset (10 cases) was associated with tubulointerstitial lesions in the form of oxalate nephropathy (50%) and/or a pigmented tubulopathy (80%). This latter was correlated with treatment with antiviral agents (p = 0.002) and aminoside and glycopeptide antibiotics (p = 0.03) administered in the month preceding biopsy. Lesions in late episodes of accelerated RFL (5 cases) were principally vascular: arteriosclerosis and arteriolosclerosis (p = 0.007, p = 0.00002), correlated with diabetic glomerulosclerosis or focal segmental glomerulosclerosis in the absence of prominent diabetic changes. Specific calcineurin-inhibitor nephrotoxicity was present in 93.3% of biopsies associated with thrombotic microangiopathy in 46.7% of cases. The identification of specific etiologies of progressive kidney disease in patients with CF after lung transplantation should permit more effective post-transplant care of these patients.
我们分析了接受肺移植的囊性纤维化(CF)患者围手术期后肾功能的演变情况,并对15例因肾功能加速丧失(RFL)发作而接受活检的患者进行了组织学分析。围手术期后发生加速RFL发作的患者占32.5%,显著增加了终末期肾病(ESRD)的风险(p < 0.001)。与这些发作相关的组织学病变因发病时间而异。早期发作(10例)与草酸盐肾病(50%)和/或色素沉着性肾小管病(80%)形式的肾小管间质病变有关。后者与活检前一个月使用抗病毒药物(p = 0.002)以及氨基糖苷类和糖肽类抗生素(p = 0.03)治疗有关。加速RFL晚期发作(5例)的病变主要是血管性的:动脉硬化和小动脉硬化(p = 0.007,p = 0.00002),与糖尿病肾小球硬化或局灶节段性肾小球硬化相关,且无明显糖尿病改变。在93.3%的活检中存在特异性钙调神经磷酸酶抑制剂肾毒性,46.7%的病例伴有血栓性微血管病。确定肺移植后CF患者进行性肾病的具体病因应能使这些患者在移植后得到更有效的护理。